ClinicalTrials.Veeva

Menu

Increasing the Removal of Protein-Bound Solutes During Extended Hours Hemodialysis

P

Palo Alto Veterans Institute for Research

Status

Unknown

Conditions

End Stage Renal Failure on Dialysis

Treatments

Other: high dialysate flow, larger dialyzer
Other: low dialysate flow, smaller dialyzer

Study type

Interventional

Funder types

Other

Identifiers

NCT01892839
MEY0026APR

Details and patient eligibility

About

Hemodialysis keeps patients with renal failure alive but does not restore normal health. Retention of chemicals that bind to plasma proteins and are therefore poorly removed by dialysis may contribute to ill health in patients receiving conventional treatment. This proposal will test the effect of a new method designed to improve the removal of protein-bound solutes during dialysis. The effects on blood chemical levels of two different dialysis prescriptions will be tested in patients already undergoing nocturnal in-center hemodialysis three times weekly.

Enrollment

24 estimated patients

Sex

All

Ages

18 to 85 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • stable on nocturnal in-center dialysis located close to Stanford University and VA Palo Alto

Exclusion criteria

  • recent use of antibiotics
  • gastrointestinal disease

Trial design

Primary purpose

Basic Science

Allocation

Randomized

Interventional model

Crossover Assignment

Masking

None (Open label)

24 participants in 2 patient groups

high dialysate flow, larger dialyzer
Experimental group
Description:
high dialysate flow, larger dialyzer
Treatment:
Other: high dialysate flow, larger dialyzer
low dialysate flow, smaller dialyzer
Active Comparator group
Description:
low dialysate flow, smaller dialyzer
Treatment:
Other: low dialysate flow, smaller dialyzer

Trial contacts and locations

2

Loading...

Central trial contact

tim meyer, md

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems